ASFOTASE ALFA

ASFOTASE ALFA was reported 10322 times

ASFOTASE ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EYELID CALCIFICATION 5 0.7143
1 VITAMIN B6 DECREASED 166 0.6510
2 VITAMIN B6 ABNORMAL 20 0.6061
3 VITAMIN B6 INCREASED 91 0.4550
4 HYPOPHOSPHATASIA 42 0.3717
5 PSEUDOFRACTURE 6 0.3158
6 INJECTION SITE HYPERTROPHY 51 0.1564
7 INJECTION SITE DEFORMATION 13 0.1461
8 BLOOD ALKALINE PHOSPHATASE DECREASED 113 0.1191
9 INJECTION SITE ATROPHY 166 0.1009
10 CONJUNCTIVAL DEPOSIT 4 0.0851
11 VITAMIN B6 DEFICIENCY 20 0.0813
12 RICKETS 15 0.0794
13 BLOOD ALKALINE PHOSPHATASE ABNORMAL 53 0.0589
14 X-RAY LIMB ABNORMAL 5 0.0549
15 TOOTH HYPOPLASIA 9 0.0517
16 CRANIOSYNOSTOSIS 43 0.0497
17 CONGENITAL BOWING OF LONG BONES 4 0.0494
18 LIPOHYPERTROPHY 30 0.0482
19 INJECTION SITE CALCIFICATION 6 0.0480
20 NEPHROCALCINOSIS 52 0.0438
21 WALKING DISTANCE TEST ABNORMAL 16 0.0409
22 LIPODYSTROPHY ACQUIRED 86 0.0405
23 INADVERTENT INJECTION AIR BUBBLE 5 0.0397
24 CALCINOSIS 77 0.0344
25 ANTI-THYROID ANTIBODY INCREASED 4 0.0317
26 URINE CALCIUM INCREASED 10 0.0317
27 CREATININE URINE DECREASED 5 0.0316
28 ALBUMIN GLOBULIN RATIO INCREASED 4 0.0292
29 BONE DEFORMITY 19 0.0283
30 EHLERS-DANLOS SYNDROME 13 0.0280
31 BLOOD PHOSPHORUS INCREASED 75 0.0274
32 SHORT STATURE 7 0.0267
33 HYPERMOBILITY SYNDROME 13 0.0261
34 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 10 0.0234
35 ANGIOMYOLIPOMA 5 0.0234
36 EXTRASKELETAL OSSIFICATION 5 0.0233
37 VITAMIN D INCREASED 14 0.0227
38 CUTANEOUS CALCIFICATION 4 0.0219
39 CARBON DIOXIDE DECREASED 25 0.0217
40 NEUTRALISING ANTIBODIES POSITIVE 9 0.0215
41 CHONDROCALCINOSIS 14 0.0214
42 INJECTION SITE DISCOLOURATION 267 0.0213
43 SKIN LAXITY 9 0.0205
44 HYPERCALCIURIA 10 0.0203
45 ANION GAP DECREASED 7 0.0201
46 VITAMIN D ABNORMAL 8 0.0195
47 BLOOD BILIRUBIN DECREASED 12 0.0194
48 EXPOSURE TO FUNGUS 4 0.0186
49 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 5 0.0185
50 LIPOEDEMA 7 0.0178
51 ILIOTIBIAL BAND SYNDROME 4 0.0177
52 NEEDLE FATIGUE 8 0.0175
53 ALBUMIN GLOBULIN RATIO DECREASED 4 0.0172
54 BLOOD PHOSPHORUS ABNORMAL 8 0.0170
55 JOINT SPACE NARROWING 5 0.0168
56 FAT TISSUE DECREASED 6 0.0154
57 GROWTH DISORDER 4 0.0148
58 KNEE DEFORMITY 22 0.0148
59 MUSCLE STRENGTH ABNORMAL 6 0.0143
60 BODY HEIGHT INCREASED 7 0.0143
61 BONE DEVELOPMENT ABNORMAL 4 0.0140
62 ENAMEL ANOMALY 4 0.0140
63 INJECTION RELATED REACTION 23 0.0139
64 ALANINE AMINOTRANSFERASE DECREASED 10 0.0138
65 VITAMIN B12 INCREASED 11 0.0138
66 HIP DEFORMITY 6 0.0137
67 KIDNEY SMALL 4 0.0137
68 BLOOD ALBUMIN INCREASED 12 0.0135
69 CORNEAL DEPOSITS 10 0.0134
70 MALABSORPTION FROM INJECTION SITE 4 0.0129
71 BLOOD ALKALINE PHOSPHATASE INCREASED 319 0.0128
72 JOINT HYPEREXTENSION 5 0.0128
73 ARNOLD-CHIARI MALFORMATION 12 0.0126
74 PYELOCALIECTASIS 12 0.0125
75 CATARACT NUCLEAR 8 0.0120
76 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 16 0.0118
77 BLOOD CHLORIDE INCREASED 20 0.0116
78 LIPOATROPHY 11 0.0116
79 MEDIAL TIBIAL STRESS SYNDROME 4 0.0115
80 ASPARTATE AMINOTRANSFERASE DECREASED 6 0.0113
81 INJECTION SITE REACTION 778 0.0113
82 DEGENERATIVE BONE DISEASE 5 0.0113
83 BLOOD CREATININE DECREASED 35 0.0112
84 FRACTURE PAIN 6 0.0111
85 VITAMIN D DECREASED 95 0.0111
86 MEIBOMIAN GLAND DYSFUNCTION 5 0.0110
87 PRESBYOPIA 6 0.0108
88 MAST CELL ACTIVATION SYNDROME 15 0.0107
89 GROWTH HORMONE DEFICIENCY 4 0.0101
90 BONE DENSITY INCREASED 4 0.0100
91 LOOSE TOOTH 32 0.0099
92 AMINO ACID LEVEL INCREASED 7 0.0094
93 BONE SCAN ABNORMAL 4 0.0094
94 BLOOD PARATHYROID HORMONE INCREASED 26 0.0089
95 MUSCLE DISCOMFORT 7 0.0089
96 BLOOD UREA DECREASED 11 0.0088
97 GROWTH RETARDATION 26 0.0088
98 INJECTION SITE SCAR 25 0.0088
99 INJECTION SITE INDENTATION 19 0.0088
100 SKIN TEXTURE ABNORMAL 8 0.0084
101 INJECTION SITE DISCOMFORT 84 0.0080
102 INJECTION SITE MASS 295 0.0080
103 SOFT TISSUE INJURY 6 0.0079
104 INJECTION SITE WARMTH 161 0.0078
105 CHONDROCALCINOSIS PYROPHOSPHATE 6 0.0078
106 SCOLIOSIS 45 0.0073
107 BONE FRAGMENTATION 4 0.0071
108 JOINT INSTABILITY 10 0.0071
109 INJECTION SITE ERYTHEMA 881 0.0071
110 CRANIOFACIAL FRACTURE 6 0.0070
111 INJECTION SITE INDURATION 90 0.0069
112 HAEMATOMA INFECTION 4 0.0069
113 INJECTION SITE HYPERSENSITIVITY 21 0.0067
114 STRESS FRACTURE 36 0.0067
115 INJECTION SITE DRYNESS 6 0.0066
116 SELECTIVE EATING DISORDER 6 0.0066
117 FOOT FRACTURE 125 0.0066
118 FEBRILE CONVULSION 8 0.0066
119 INJECTION SITE BRUISING 513 0.0064
120 BRAIN FOG 100 0.0064
121 INJECTION SITE ULCER 6 0.0064
122 BLOOD PARATHYROID HORMONE ABNORMAL 4 0.0063
123 BREAST CALCIFICATIONS 5 0.0063
124 ACTIVITIES OF DAILY LIVING DECREASED 4 0.0063
125 CORTISOL DECREASED 7 0.0061
126 JOINT NOISE 12 0.0061
127 BLOOD CALCIUM ABNORMAL 10 0.0060
128 MEAN PLATELET VOLUME DECREASED 5 0.0060
129 ASTIGMATISM 9 0.0059
130 INJECTION SITE URTICARIA 145 0.0059
131 INJECTION SITE SWELLING 442 0.0058
132 CARTILAGE INJURY 14 0.0057
133 LIMB DEFORMITY 9 0.0057
134 KYPHOSIS 10 0.0057
135 BLOOD MAGNESIUM INCREASED 5 0.0055
136 BONE PAIN 323 0.0055
137 LIGAMENT DISORDER 5 0.0055
138 RETINAL DEGENERATION 7 0.0054
139 PITUITARY TUMOUR 8 0.0054
140 BLOOD UREA ABNORMAL 5 0.0053
141 INTUSSUSCEPTION 5 0.0052
142 TOOTH LOSS 108 0.0052
143 RENAL CYST 41 0.0052
144 CARBON DIOXIDE INCREASED 7 0.0051
145 INJECTION SITE PRURITUS 344 0.0051
146 EXPOSURE VIA BODY FLUID 4 0.0051
147 HIGH DENSITY LIPOPROTEIN INCREASED 5 0.0050
148 INJECTION SITE RASH 154 0.0050
149 LIMB MASS 11 0.0050
150 ATTENTION DEFICIT HYPERACTIVITY DISORDER 21 0.0050
151 INJECTION SITE IRRITATION 63 0.0049
152 INJECTION SITE HYPOAESTHESIA 7 0.0049
153 HAND-FOOT-AND-MOUTH DISEASE 4 0.0048
154 INJECTION SITE INFLAMMATION 24 0.0048
155 SPINAL DEFORMITY 8 0.0048
156 COCCYDYNIA 7 0.0047
157 FRACTURE DELAYED UNION 4 0.0047
158 BLOOD PARATHYROID HORMONE DECREASED 7 0.0047
159 BLOOD CHLORIDE DECREASED 12 0.0046
160 LACK OF INJECTION SITE ROTATION 8 0.0046
161 INJECTION SITE PARAESTHESIA 7 0.0046
162 SUSPECTED COVID-19 15 0.0045
163 OSTEOMALACIA 7 0.0045
164 SKIN WRINKLING 12 0.0044
165 INJECTION SITE PAIN 1351 0.0044
166 BONE CONTUSION 4 0.0044
167 FEAR OF INJECTION 31 0.0043
168 BODY TEMPERATURE ABNORMAL 8 0.0043
169 HAEMOCHROMATOSIS 4 0.0043
170 INJECTION SITE CELLULITIS 8 0.0043
171 BONE CYST 4 0.0043
172 CONNECTIVE TISSUE DISORDER 6 0.0042
173 HYPERMETROPIA 4 0.0042
174 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 7 0.0042
175 HYPERPHOSPHATAEMIA 9 0.0042
176 THYROID MASS 16 0.0042
177 BLOOD URINE 4 0.0041
178 SKIN STRIAE 6 0.0040
179 BONE DENSITY ABNORMAL 15 0.0040
180 SYMPTOM RECURRENCE 24 0.0040
181 RENAL ATROPHY 5 0.0040
182 MENTAL FATIGUE 6 0.0040
183 SKIN ATROPHY 23 0.0040
184 HYPERAESTHESIA TEETH 5 0.0040
185 FRACTURED COCCYX 5 0.0039
186 SKIN HYPERTROPHY 11 0.0039
187 TOOTH FRACTURE 43 0.0039
188 BLOOD CALCIUM INCREASED 34 0.0039
189 OSTEOSCLEROSIS 6 0.0038
190 KERATOPATHY 6 0.0038
191 PROTEIN TOTAL INCREASED 10 0.0038
192 ANION GAP INCREASED 5 0.0037
193 INJECTION SITE NODULE 41 0.0037
194 WEIGHT BEARING DIFFICULTY 10 0.0037
195 FRACTURE NONUNION 5 0.0037
196 FRACTURE 69 0.0036
197 TIBIA FRACTURE 17 0.0036
198 BLOOD PHOSPHORUS DECREASED 13 0.0036
199 TYMPANIC MEMBRANE PERFORATION 6 0.0035
200 MENOPAUSE 9 0.0035
201 DYSLEXIA 4 0.0035
202 INJECTION SITE VESICLES 21 0.0035
203 FAT TISSUE INCREASED 5 0.0034
204 AUTONOMIC NERVOUS SYSTEM IMBALANCE 10 0.0034
205 MAGNETIC RESONANCE IMAGING ABNORMAL 4 0.0033
206 LIGAMENT SPRAIN 33 0.0033
207 CLUMSINESS 9 0.0033
208 MEAN CELL HAEMOGLOBIN DECREASED 6 0.0033
209 RUBBER SENSITIVITY 5 0.0033
210 HAND FRACTURE 23 0.0032
211 VITREOUS DETACHMENT 7 0.0032
212 DENTAL CARIES 35 0.0032
213 LOW DENSITY LIPOPROTEIN INCREASED 24 0.0031
214 ATROPHY 6 0.0031
215 MUSCLE FATIGUE 13 0.0031
216 MEAN CELL HAEMOGLOBIN INCREASED 5 0.0030
217 TOOTH DISORDER 66 0.0030
218 EXOSTOSIS 27 0.0030
219 DRUG SPECIFIC ANTIBODY 4 0.0029
220 PROTEIN TOTAL DECREASED 11 0.0029
221 CORNEAL ABRASION 4 0.0029
222 INJECTION SITE OEDEMA 5 0.0029
223 TEMPERATURE INTOLERANCE 30 0.0029
224 SKIN INDURATION 6 0.0029
225 TENDERNESS 30 0.0029
226 BLOOD UREA INCREASED 47 0.0028
227 EXERCISE TOLERANCE DECREASED 16 0.0028
228 PHARYNGITIS STREPTOCOCCAL 30 0.0028
229 AUTOIMMUNE DISORDER 27 0.0028
230 INJECTION SITE INFECTION 9 0.0027
231 MEAN CELL VOLUME INCREASED 7 0.0027
232 PRODUCT TEMPERATURE EXCURSION ISSUE 14 0.0027
233 BILIARY DILATATION 4 0.0027
234 DARK CIRCLES UNDER EYES 4 0.0027
235 BLOOD THYROID STIMULATING HORMONE ABNORMAL 5 0.0027
236 SENSITIVE SKIN 20 0.0027
237 OSTEOPENIA 41 0.0027
238 INFECTIOUS MONONUCLEOSIS 6 0.0027
239 NARCOLEPSY 5 0.0026
240 JOINT DISLOCATION 28 0.0026
241 PERIARTHRITIS 6 0.0026
242 ASPARTATE AMINOTRANSFERASE ABNORMAL 4 0.0026
243 MEAN CELL VOLUME DECREASED 4 0.0026
244 RESPIRATORY TRACT INFECTION VIRAL 6 0.0026
245 PATELLA FRACTURE 6 0.0026
246 INSURANCE ISSUE 39 0.0025
247 AUTISM SPECTRUM DISORDER 14 0.0025
248 UNDERWEIGHT 5 0.0025
249 GENE MUTATION 5 0.0025
250 MYOPIA 6 0.0025
251 STREPTOCOCCAL INFECTION 14 0.0025
252 WRIST FRACTURE 30 0.0025
253 WEIGHT ABNORMAL 6 0.0025
254 NEPHROLITHIASIS 113 0.0025
255 RENAL MASS 5 0.0024
256 BONE DENSITY DECREASED 76 0.0024
257 RED CELL DISTRIBUTION WIDTH INCREASED 10 0.0024
258 WALKING DISABILITY 5 0.0024
259 TOOTH DISCOLOURATION 7 0.0024
260 SLEEP DEFICIT 5 0.0024
261 CREPITATIONS 7 0.0023
262 URINE ANALYSIS ABNORMAL 7 0.0023
263 BLOOD TESTOSTERONE DECREASED 16 0.0023
264 AORTIC ARTERIOSCLEROSIS 6 0.0023
265 BLOOD TESTOSTERONE INCREASED 5 0.0023
266 TOOTH INJURY 10 0.0023
267 SKIN REACTION 32 0.0023
268 MIDDLE EAR EFFUSION 5 0.0023
269 LIGAMENT RUPTURE 10 0.0023
270 BLOOD POTASSIUM ABNORMAL 6 0.0022
271 INDURATION 4 0.0022
272 TEMPOROMANDIBULAR JOINT SYNDROME 6 0.0022
273 FRUSTRATION TOLERANCE DECREASED 18 0.0022
274 GLOMERULAR FILTRATION RATE DECREASED 27 0.0022
275 HAEMATOCRIT INCREASED 5 0.0022
276 CALCIPHYLAXIS 4 0.0022
277 ORAL PRURITUS 5 0.0022
278 LABORATORY TEST ABNORMAL 64 0.0022
279 OSTEOPOROSIS 89 0.0022
280 EAR INFECTION 57 0.0021
281 SPINAL PAIN 25 0.0021
282 AUTOIMMUNE THYROIDITIS 8 0.0021
283 HIGH DENSITY LIPOPROTEIN DECREASED 7 0.0021
284 GINGIVAL RECESSION 4 0.0021
285 MUSCLE STRAIN 18 0.0021
286 FOOT DEFORMITY 23 0.0021
287 HUMERUS FRACTURE 10 0.0021
288 FINE MOTOR SKILL DYSFUNCTION 6 0.0021
289 INJECTION SITE DISCHARGE 11 0.0020
290 MUSCLE TIGHTNESS 33 0.0020
291 BONE DISORDER 37 0.0020
292 BLOOD IMMUNOGLOBULIN G DECREASED 5 0.0020
293 DERMATOMYOSITIS 5 0.0020
294 INJECTION SITE NECROSIS 4 0.0020
295 BLOOD THYROID STIMULATING HORMONE INCREASED 18 0.0020
296 GASTROENTERITIS VIRAL 35 0.0019
297 LIVEDO RETICULARIS 4 0.0019
298 PAIN IN EXTREMITY 564 0.0019
299 SKIN TIGHTNESS 9 0.0019
300 ONYCHOMADESIS 8 0.0019
301 RADICULOPATHY 5 0.0019
302 ARTHROPOD BITE 14 0.0019
303 ENDOMETRIOSIS 9 0.0019
304 MUSCULOSKELETAL CHEST PAIN 29 0.0019
305 TENDON PAIN 14 0.0018
306 INCREASED TENDENCY TO BRUISE 17 0.0018
307 ANTINUCLEAR ANTIBODY POSITIVE 6 0.0018
308 LYMPHOCYTE COUNT INCREASED 6 0.0018
309 RED BLOOD CELL COUNT INCREASED 5 0.0018
310 SKIN INJURY 6 0.0018
311 FAECES PALE 4 0.0018
312 SKIN MASS 12 0.0018
313 PLANTAR FASCIITIS 6 0.0018
314 BLOOD CALCIUM DECREASED 20 0.0018
315 SPEECH DISORDER DEVELOPMENTAL 5 0.0017
316 MUSCULOSKELETAL DISCOMFORT 30 0.0017
317 FAILURE TO THRIVE 9 0.0017
318 SYNOVIAL CYST 8 0.0017
319 HAEMANGIOMA 4 0.0017
320 BREAKTHROUGH PAIN 4 0.0017
321 MENOPAUSAL SYMPTOMS 4 0.0017
322 ARTHRALGIA 713 0.0017
323 TROPONIN INCREASED 13 0.0017
324 HYPERCALCAEMIA 21 0.0017
325 SPINAL STENOSIS 7 0.0017
326 SEASONAL ALLERGY 24 0.0017
327 COMPRESSION FRACTURE 9 0.0017
328 NECK PAIN 93 0.0017
329 LIMB INJURY 45 0.0017
330 HYDROCEPHALUS 9 0.0017
331 BURSITIS 20 0.0016
332 BLOOD ALBUMIN DECREASED 13 0.0016
333 MENISCUS INJURY 10 0.0016
334 NERVE COMPRESSION 15 0.0016
335 TENDON INJURY 6 0.0016
336 TALIPES 5 0.0016
337 MUSCLE DISORDER 13 0.0016
338 HYPOTONIA 16 0.0016
339 JOINT STIFFNESS 42 0.0016
340 CLAVICLE FRACTURE 6 0.0016
341 VARICOSE VEIN 8 0.0015
342 TOOTHACHE 28 0.0015
343 CONTUSION 148 0.0015
344 TENDON DISORDER 10 0.0015
345 DEAFNESS 40 0.0015
346 VITREOUS FLOATERS 15 0.0015
347 POLYDIPSIA 6 0.0015
348 RIB FRACTURE 31 0.0015
349 OVARIAN CYST 15 0.0015
350 LYME DISEASE 5 0.0015
351 JOINT INJURY 32 0.0015
352 BLOOD SODIUM INCREASED 4 0.0015
353 CHONDROPATHY 4 0.0015
354 EAR CONGESTION 4 0.0015
355 VIRAL UPPER RESPIRATORY TRACT INFECTION 7 0.0015
356 HYDRONEPHROSIS 11 0.0015
357 LIP BLISTER 4 0.0015
358 UPPER LIMB FRACTURE 29 0.0015
359 NEURALGIA 35 0.0014
360 INTRACRANIAL PRESSURE INCREASED 8 0.0014
361 HORMONE LEVEL ABNORMAL 7 0.0014
362 MASS 20 0.0014
363 ELECTRIC SHOCK SENSATION 4 0.0014
364 TENDONITIS 22 0.0014
365 ABDOMINAL TENDERNESS 7 0.0014
366 LOWER LIMB FRACTURE 27 0.0014
367 ROTATOR CUFF SYNDROME 18 0.0014
368 POOR QUALITY SLEEP 30 0.0014
369 INJECTION SITE HAEMORRHAGE 111 0.0014
370 LIMB DISCOMFORT 43 0.0014
371 FEMUR FRACTURE 43 0.0014
372 ILLNESS 143 0.0014
373 MYALGIA 236 0.0014
374 PARAESTHESIA ORAL 20 0.0014
375 BONE LESION 5 0.0014
376 PAIN 851 0.0014
377 PATHOLOGICAL FRACTURE 7 0.0014
378 MONOCYTE COUNT INCREASED 5 0.0014
379 SPONDYLITIS 5 0.0014
380 SPINAL DISORDER 13 0.0014
381 MIGRAINE 128 0.0013
382 VITAMIN D DEFICIENCY 13 0.0013
383 MUSCULAR WEAKNESS 151 0.0013
384 SNORING 5 0.0013
385 FATIGUE 1029 0.0013
386 RENAL PAIN 14 0.0013
387 DERMATITIS CONTACT 15 0.0013
388 LUMBAR VERTEBRAL FRACTURE 6 0.0013
389 ANKLE FRACTURE 20 0.0013
390 CYST 16 0.0013
391 ROSACEA 6 0.0013
392 MUSCLE RUPTURE 5 0.0013
393 FIBROMYALGIA 31 0.0013
394 DEAFNESS UNILATERAL 7 0.0013
395 JOINT RANGE OF MOTION DECREASED 17 0.0013
396 MUSCULOSKELETAL STIFFNESS 111 0.0013
397 BACK PAIN 292 0.0013
398 GRIP STRENGTH DECREASED 11 0.0012
399 CARDIAC FLUTTER 8 0.0012
400 EAR PAIN 24 0.0012
401 WEIGHT INCREASED 276 0.0012
402 FACET JOINT SYNDROME 4 0.0012
403 NEUROLOGICAL SYMPTOM 7 0.0012
404 TRIGGER FINGER 5 0.0012
405 DEAFNESS NEUROSENSORY 4 0.0012
406 ANAPHYLACTOID REACTION 5 0.0012
407 WALKING AID USER 8 0.0012
408 SLEEP APNOEA SYNDROME 23 0.0012
409 INFLUENZA 133 0.0012
410 TONGUE DISCOMFORT 5 0.0012
411 SLUGGISHNESS 12 0.0012
412 SKIN DISCOLOURATION 54 0.0012
413 NEUTROPHIL COUNT INCREASED 12 0.0012
414 HEPATIC PAIN 5 0.0012
415 CONCUSSION 9 0.0012
416 HAEMATOCRIT DECREASED 23 0.0012
417 BLOOD CREATININE ABNORMAL 4 0.0012
418 HORDEOLUM 5 0.0012
419 ADRENAL INSUFFICIENCY 14 0.0012
420 MALABSORPTION 6 0.0011
421 WEIGHT FLUCTUATION 12 0.0011
422 SENSITIVITY TO WEATHER CHANGE 6 0.0011
423 SCIATICA 18 0.0011
424 IMPAIRED HEALING 37 0.0011
425 HEPATOMEGALY 11 0.0011
426 BLOOD SODIUM DECREASED 21 0.0011
427 DECREASED ACTIVITY 12 0.0011
428 PAPILLOEDEMA 5 0.0011
429 BACK INJURY 12 0.0011
430 BLOOD THYROID STIMULATING HORMONE DECREASED 5 0.0011
431 URINE ABNORMALITY 5 0.0011
432 INTERVERTEBRAL DISC PROTRUSION 24 0.0011
433 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0011
434 ARTHRITIS 85 0.0011
435 DRUG SPECIFIC ANTIBODY PRESENT 7 0.0011
436 MUSCULOSKELETAL PAIN 56 0.0011
437 SENSATION OF FOREIGN BODY 9 0.0011
438 FLANK PAIN 10 0.0011
439 CHRONIC SINUSITIS 4 0.0011
440 THIRST 19 0.0011
441 POOR VENOUS ACCESS 11 0.0011
442 SEIZURE 121 0.0010
443 HYPERSOMNIA 30 0.0010
444 GASTRIC INFECTION 4 0.0010
445 BLOOD MAGNESIUM DECREASED 9 0.0010
446 BREAST MASS 7 0.0010
447 NEUROPATHY PERIPHERAL 99 0.0010
448 THYROID DISORDER 16 0.0010
449 MULTIPLE FRACTURES 17 0.0010
450 RESPIRATORY SYNCYTIAL VIRUS INFECTION 9 0.0010
451 DYSSTASIA 30 0.0010
452 IMPAIRED GASTRIC EMPTYING 14 0.0010
453 SPINAL OSTEOARTHRITIS 9 0.0010
454 VIRAL INFECTION 34 0.0010
455 SKIN DISORDER 34 0.0010
456 HEAD DISCOMFORT 18 0.0010
457 PANCREATIC DISORDER 5 0.0010
458 LYMPHOEDEMA 7 0.0010
459 GASTROINTESTINAL INFECTION 9 0.0010
460 PROTEIN URINE PRESENT 5 0.0010
461 THROAT TIGHTNESS 27 0.0010
462 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
463 ENURESIS 4 0.0010
464 CHILLS 116 0.0010
465 INCORRECT PRODUCT STORAGE 13 0.0010
466 GAIT DISTURBANCE 189 0.0010
467 ANKYLOSING SPONDYLITIS 13 0.0010
468 TOOTH INFECTION 13 0.0010
469 BLOOD POTASSIUM INCREASED 16 0.0010
470 PETIT MAL EPILEPSY 5 0.0010
471 ASPARTATE AMINOTRANSFERASE INCREASED 51 0.0010
472 PARTIAL SEIZURES 5 0.0010
473 UPPER RESPIRATORY TRACT INFECTION 44 0.0010
474 PRODUCT USE COMPLAINT 15 0.0010
475 GLYCOSYLATED HAEMOGLOBIN INCREASED 24 0.0009
476 OSTEOARTHRITIS 40 0.0009
477 DRY EYE 47 0.0009
478 PRODUCT ADMINISTRATION ERROR 19 0.0009
479 CRYING 34 0.0009
480 BODY HEIGHT DECREASED 10 0.0009
481 WEIGHT DECREASED 261 0.0009
482 RESTLESS LEGS SYNDROME 17 0.0009
483 BONE LOSS 14 0.0009
484 HEPATIC LESION 4 0.0009
485 SKIN SWELLING 8 0.0009
486 CHAPPED LIPS 4 0.0009
487 PHARYNGEAL SWELLING 9 0.0009
488 NODULE 12 0.0009
489 COELIAC DISEASE 9 0.0009
490 POLYP 6 0.0009
491 PRODUCT PREPARATION ISSUE 6 0.0009
492 JAW DISORDER 5 0.0009
493 INJECTION SITE INJURY 5 0.0009
494 APNOEA 7 0.0009
495 POST-TRAUMATIC STRESS DISORDER 6 0.0009
496 MUSCULOSKELETAL DISORDER 17 0.0009
497 POSTOPERATIVE WOUND INFECTION 6 0.0009
498 TOOTH ABSCESS 9 0.0009
499 HAEMOGLOBIN INCREASED 4 0.0009
500 SCAR 15 0.0009
501 PERIPHERAL COLDNESS 12 0.0009
502 EAR DISORDER 4 0.0009
503 RETINAL DETACHMENT 8 0.0009
504 JOINT EFFUSION 6 0.0009
505 HAIR GROWTH ABNORMAL 6 0.0009
506 LARGE INTESTINE POLYP 6 0.0009
507 BLOOD CHOLESTEROL ABNORMAL 4 0.0009
508 INTERVERTEBRAL DISC DEGENERATION 8 0.0009
509 PRESYNCOPE 21 0.0009
510 SKIN WARM 5 0.0009
511 CARPAL TUNNEL SYNDROME 12 0.0009
512 POLYURIA 7 0.0009
513 UPPER-AIRWAY COUGH SYNDROME 7 0.0008
514 SPINAL COMPRESSION FRACTURE 7 0.0008
515 GLUCOSE TOLERANCE IMPAIRED 5 0.0008
516 COLITIS MICROSCOPIC 4 0.0008
517 PROCEDURAL PAIN 23 0.0008
518 TINNITUS 38 0.0008
519 LIQUID PRODUCT PHYSICAL ISSUE 6 0.0008
520 MOBILITY DECREASED 59 0.0008
521 INJECTION SITE EXTRAVASATION 10 0.0008
522 TENDON RUPTURE 10 0.0008
523 NERVE INJURY 9 0.0008
524 HEPATIC STEATOSIS 15 0.0008
525 BACK DISORDER 13 0.0008
526 SWELLING OF EYELID 5 0.0008
527 MUSCLE ATROPHY 10 0.0008
528 SYSTEMIC LUPUS ERYTHEMATOSUS 28 0.0008
529 PERIPHERAL SWELLING 121 0.0008
530 SCREAMING 5 0.0008
531 BLOOD TEST ABNORMAL 11 0.0008
532 FEMORAL NECK FRACTURE 4 0.0008
533 ANAL INCONTINENCE 7 0.0008
534 FOOD ALLERGY 6 0.0008
535 PAIN IN JAW 22 0.0008
536 INFLAMMATION 40 0.0008
537 OROPHARYNGEAL DISCOMFORT 7 0.0008
538 ARTHROPATHY 43 0.0008
539 PETECHIAE 8 0.0008
540 ROAD TRAFFIC ACCIDENT 32 0.0008
541 FEELING ABNORMAL 182 0.0008
542 BLOOD IRON DECREASED 9 0.0008
543 MUSCLE SPASMS 139 0.0008
544 SINUS DISORDER 15 0.0008
545 BRONCHITIS 56 0.0008
546 APPETITE DISORDER 5 0.0008
547 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
548 JOINT SWELLING 90 0.0007
549 SENSORY LOSS 6 0.0007
550 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 53 0.0007
551 ARTERIOSCLEROSIS 7 0.0007
552 BRONCHIECTASIS 5 0.0007
553 BEHAVIOUR DISORDER 4 0.0007
554 ANXIETY 210 0.0007
555 NASOPHARYNGITIS 136 0.0007
556 BLOOD URINE PRESENT 14 0.0007
557 SWELLING 69 0.0007
558 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
559 BLOOD TRIGLYCERIDES INCREASED 13 0.0007
560 IRRITABILITY 44 0.0007
561 ONYCHOCLASIS 5 0.0007
562 CHOKING SENSATION 4 0.0007
563 NEEDLE ISSUE 21 0.0007
564 GAIT INABILITY 24 0.0007
565 ALANINE AMINOTRANSFERASE INCREASED 44 0.0007
566 KIDNEY INFECTION 14 0.0007
567 BURNING SENSATION 50 0.0007
568 FALL 237 0.0007
569 THERAPY CHANGE 7 0.0007
570 BLOOD GLUCOSE ABNORMAL 13 0.0007
571 GASTROINTESTINAL DISORDER 63 0.0007
572 MALAISE 307 0.0007
573 PARAESTHESIA 110 0.0007
574 LIVER FUNCTION TEST INCREASED 15 0.0007
575 HYPOAESTHESIA 104 0.0007
576 BLOOD URIC ACID INCREASED 4 0.0007
577 HYPERVENTILATION 4 0.0007
578 BLOOD CREATININE INCREASED 45 0.0007
579 HYPOKINESIA 10 0.0007
580 NAIL DISORDER 6 0.0007
581 APATHY 10 0.0007
582 GASTROENTERITIS 10 0.0007
583 FEELING HOT 42 0.0007
584 NIGHT SWEATS 22 0.0007
585 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
586 PYREXIA 236 0.0007
587 SARS-COV-2 TEST POSITIVE 9 0.0007
588 DEPRESSED MOOD 36 0.0007
589 INSOMNIA 181 0.0007
590 ENERGY INCREASED 4 0.0007
591 TREATMENT NONCOMPLIANCE 37 0.0007
592 NERVOUS SYSTEM DISORDER 21 0.0007
593 ACCIDENT 8 0.0007
594 URTICARIA 112 0.0007
595 HYPERSENSITIVITY 124 0.0007
596 HEAVY MENSTRUAL BLEEDING 6 0.0007
597 DEVELOPMENTAL DELAY 6 0.0007
598 RED BLOOD CELL COUNT DECREASED 19 0.0007
599 HEADACHE 416 0.0007
600 HYPOAESTHESIA ORAL 10 0.0007
601 INCORRECT DOSE ADMINISTERED 151 0.0007
602 MOOD ALTERED 18 0.0007
603 RETCHING 14 0.0007
604 BOWEL MOVEMENT IRREGULARITY 5 0.0007
605 SLEEP DISORDER 46 0.0007
606 IRON DEFICIENCY ANAEMIA 6 0.0006
607 SPINAL FRACTURE 13 0.0006
608 COORDINATION ABNORMAL 9 0.0006
609 PHARYNGITIS 8 0.0006
610 BLOOD CHOLESTEROL INCREASED 30 0.0006
611 PELVIC FRACTURE 5 0.0006
612 DEFORMITY 6 0.0006
613 BODY TEMPERATURE INCREASED 13 0.0006
614 ASTHENIA 239 0.0006
615 BLEPHAROSPASM 4 0.0006
616 RESPIRATORY DISORDER 19 0.0006
617 SINUSITIS 65 0.0006
618 RASH MACULAR 22 0.0006
619 HYPOACUSIS 27 0.0006
620 MOVEMENT DISORDER 20 0.0006
621 RENAL DISORDER 29 0.0006
622 NERVOUSNESS 32 0.0006
623 SYNCOPE 61 0.0006
624 HYPERAESTHESIA 5 0.0006
625 DYSGRAPHIA 4 0.0006
626 PHOTOSENSITIVITY REACTION 10 0.0006
627 CATARACT 36 0.0006
628 MENSTRUAL DISORDER 5 0.0006
629 EOSINOPHIL COUNT INCREASED 5 0.0006
630 MENTAL DISORDER 26 0.0006
631 BALANCE DISORDER 51 0.0006
632 ABNORMAL LOSS OF WEIGHT 4 0.0006
633 FACIAL PARALYSIS 5 0.0006
634 INITIAL INSOMNIA 6 0.0006
635 HOT FLUSH 44 0.0006
636 ANAPHYLACTIC REACTION 32 0.0006
637 EYE DISORDER 19 0.0006
638 DEPRESSION 131 0.0006
639 FEELING COLD 16 0.0006
640 DRUG PRESCRIBING ERROR 11 0.0006
641 GLAUCOMA 11 0.0006
642 INFLUENZA LIKE ILLNESS 47 0.0006
643 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 27 0.0006
644 BLOOD PRESSURE ABNORMAL 11 0.0006
645 OSTEOMYELITIS 10 0.0006
646 SKIN LESION 15 0.0005
647 BLINDNESS TRANSIENT 4 0.0005
648 TREMOR 90 0.0005
649 COVID-19 95 0.0005
650 VERTIGO 33 0.0005
651 CEREBRAL DISORDER 4 0.0005
652 LIP SWELLING 18 0.0005
653 LETHARGY 31 0.0005
654 PULMONARY MASS 8 0.0005
655 ORAL PAIN 12 0.0005
656 NEPHROPATHY 5 0.0005
657 APPENDICITIS 5 0.0005
658 SNEEZING 12 0.0005
659 OXYGEN SATURATION DECREASED 30 0.0005
660 HYPOTHYROIDISM 17 0.0005
661 BLOOD POTASSIUM DECREASED 16 0.0005
662 PHOTOPHOBIA 10 0.0005
663 EYE INFECTION 6 0.0005
664 NASAL CONGESTION 31 0.0005
665 PRODUCT PACKAGING ISSUE 5 0.0005
666 MICTURITION URGENCY 6 0.0005
667 POST PROCEDURAL COMPLICATION 10 0.0005
668 HERNIA 10 0.0005
669 PRODUCT STORAGE ERROR 45 0.0005
670 HEART RATE DECREASED 18 0.0005
671 COLD SWEAT 9 0.0005
672 CYANOSIS 8 0.0005
673 DISCOMFORT 31 0.0005
674 DIVERTICULITIS 14 0.0005
675 GALLBLADDER DISORDER 9 0.0005
676 MUSCLE RIGIDITY 6 0.0005
677 HIP FRACTURE 16 0.0005
678 ERYTHEMA 102 0.0005
679 DIZZINESS 246 0.0005
680 GASTROOESOPHAGEAL REFLUX DISEASE 39 0.0005
681 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
682 LYMPHADENOPATHY 17 0.0005
683 PALLOR 13 0.0005
684 MUSCLE TWITCHING 11 0.0005
685 HYPOCALCAEMIA 9 0.0005
686 HYPERHIDROSIS 61 0.0005
687 EATING DISORDER 10 0.0005
688 PALPITATIONS 55 0.0005
689 PANIC ATTACK 17 0.0005
690 COUGH 130 0.0005
691 DISTURBANCE IN ATTENTION 25 0.0005
692 HIATUS HERNIA 6 0.0005
693 CARDIAC MURMUR 4 0.0005
694 RESPIRATORY TRACT INFECTION 12 0.0005
695 PLATELET COUNT INCREASED 6 0.0005
696 GROIN PAIN 4 0.0005
697 SOMNOLENCE 91 0.0005
698 FACIAL PAIN 4 0.0004
699 THROAT IRRITATION 20 0.0004
700 THERAPY NON-RESPONDER 20 0.0004
701 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
702 FLUSHING 45 0.0004
703 HEAD INJURY 14 0.0004
704 UVEITIS 6 0.0004
705 LIP DRY 4 0.0004
706 OBESITY 7 0.0004
707 MOOD SWINGS 14 0.0004
708 CENTRAL NERVOUS SYSTEM LESION 6 0.0004
709 RESPIRATORY DISTRESS 12 0.0004
710 CONJUNCTIVITIS 8 0.0004
711 CHOLELITHIASIS 14 0.0004
712 SPLENOMEGALY 5 0.0004
713 EMOTIONAL DISORDER 13 0.0004
714 OROPHARYNGEAL PAIN 39 0.0004
715 CONDITION AGGRAVATED 128 0.0004
716 EYE INFLAMMATION 4 0.0004
717 PARALYSIS 6 0.0004
718 MACULAR DEGENERATION 5 0.0004
719 INCREASED APPETITE 8 0.0004
720 HYPERTHYROIDISM 6 0.0004
721 HEART RATE INCREASED 41 0.0004
722 PRODUCT DOSE OMISSION 27 0.0004
723 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
724 C-REACTIVE PROTEIN INCREASED 15 0.0004
725 MENSTRUATION IRREGULAR 11 0.0004
726 LOSS OF CONSCIOUSNESS 52 0.0004
727 PRODUCT DOSE OMISSION ISSUE 119 0.0004
728 INABILITY TO AFFORD MEDICATION 4 0.0004
729 IMMUNODEFICIENCY 6 0.0004
730 SYRINGE ISSUE 7 0.0004
731 SWELLING FACE 26 0.0004
732 VOMITING 186 0.0004
733 NAUSEA 313 0.0004
734 EYELID PTOSIS 4 0.0004
735 GOUT 7 0.0004
736 MYDRIASIS 5 0.0004
737 EAR DISCOMFORT 4 0.0004
738 MEMORY IMPAIRMENT 53 0.0004
739 COGNITIVE DISORDER 18 0.0004
740 PULMONARY HYPERTENSION 8 0.0004
741 HERPES ZOSTER 22 0.0004
742 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 7 0.0004
743 CHEST DISCOMFORT 39 0.0004
744 BEDRIDDEN 5 0.0004
745 PNEUMONIA 123 0.0004
746 VISUAL IMPAIRMENT 47 0.0004
747 INCONTINENCE 4 0.0004
748 ULCER 6 0.0004
749 DYSPHONIA 22 0.0004
750 THINKING ABNORMAL 7 0.0004
751 BACTERIAL INFECTION 7 0.0004
752 LOWER RESPIRATORY TRACT INFECTION 17 0.0004
753 IRRITABLE BOWEL SYNDROME 8 0.0004
754 BLOOD PRESSURE INCREASED 57 0.0004
755 QUALITY OF LIFE DECREASED 5 0.0004
756 CHEST PAIN 69 0.0004
757 EYE PAIN 21 0.0004
758 DYSPNOEA EXERTIONAL 14 0.0004
759 SKIN CANCER 8 0.0004
760 BLOOD GLUCOSE INCREASED 70 0.0004
761 MENTAL IMPAIRMENT 9 0.0004
762 URINARY INCONTINENCE 11 0.0004
763 RASH PRURITIC 20 0.0004
764 BIPOLAR DISORDER 4 0.0004
765 ASPIRATION 4 0.0004
766 BLOOD GLUCOSE FLUCTUATION 4 0.0004
767 STAPHYLOCOCCAL INFECTION 12 0.0004
768 GASTROINTESTINAL PAIN 4 0.0004
769 CONSTIPATION 79 0.0004
770 EPILEPSY 11 0.0004
771 WOUND 10 0.0004
772 VISION BLURRED 49 0.0004
773 UNDERDOSE 26 0.0004
774 TRANSIENT ISCHAEMIC ATTACK 12 0.0004
775 CANDIDA INFECTION 6 0.0004
776 ANGER 12 0.0004
777 HEMIPARESIS 6 0.0004
778 BLOOD GLUCOSE DECREASED 17 0.0004
779 EXPOSURE DURING PREGNANCY 22 0.0004
780 CIRCULATORY COLLAPSE 6 0.0004
781 SWOLLEN TONGUE 11 0.0004
782 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 6 0.0003
783 PREGNANCY 7 0.0003
784 URINARY TRACT INFECTION 59 0.0003
785 ANOSMIA 5 0.0003
786 ABDOMINAL DISTENSION 36 0.0003
787 DYSPNOEA 195 0.0003
788 ABDOMINAL PAIN UPPER 70 0.0003
789 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
790 ABDOMINAL PAIN 78 0.0003
791 HYPERLIPIDAEMIA 4 0.0003
792 PELVIC PAIN 6 0.0003
793 ABNORMAL BEHAVIOUR 13 0.0003
794 RESPIRATORY ARREST 9 0.0003
795 HIP ARTHROPLASTY 5 0.0003
796 HAEMATOCHEZIA 18 0.0003
797 RHINORRHOEA 21 0.0003
798 PRURITUS GENERALISED 7 0.0003
799 RASH 141 0.0003
800 ASTHMA 36 0.0003
801 RHEUMATOID ARTHRITIS 36 0.0003
802 COLITIS 12 0.0003
803 FLUID RETENTION 16 0.0003
804 DECREASED APPETITE 73 0.0003
805 PULMONARY FIBROSIS 6 0.0003
806 SENSORY DISTURBANCE 5 0.0003
807 GENERAL PHYSICAL HEALTH DETERIORATION 36 0.0003
808 CHROMATURIA 7 0.0003
809 HEART RATE IRREGULAR 7 0.0003
810 DYSPHAGIA 29 0.0003
811 SPEECH DISORDER 16 0.0003
812 DYSPEPSIA 30 0.0003
813 IMMUNE SYSTEM DISORDER 4 0.0003
814 ADVERSE REACTION 4 0.0003
815 BLOOD PRESSURE DECREASED 20 0.0003
816 DEHYDRATION 40 0.0003
817 URINARY RETENTION 10 0.0003
818 CARDIAC DISORDER 28 0.0003
819 MALIGNANT MELANOMA 4 0.0003
820 CELLULITIS 15 0.0003
821 PAIN OF SKIN 8 0.0003
822 OCULAR HYPERAEMIA 14 0.0003
823 HEPATIC ENZYME INCREASED 20 0.0003
824 POLLAKIURIA 12 0.0003
825 DERMATITIS 6 0.0003
826 ABDOMINAL DISCOMFORT 48 0.0003
827 ENCEPHALOPATHY 7 0.0003
828 LYMPHOCYTE COUNT DECREASED 5 0.0003
829 HAEMOGLOBIN DECREASED 29 0.0003
830 PRURITUS 108 0.0003
831 INJECTION SITE HAEMATOMA 4 0.0003
832 COMPLICATION ASSOCIATED WITH DEVICE 4 0.0003
833 ANAPHYLACTIC SHOCK 7 0.0003
834 LIVER DISORDER 12 0.0003
835 DIPLOPIA 7 0.0003
836 EYE SWELLING 10 0.0003
837 COLON CANCER 4 0.0003
838 EYE PRURITUS 9 0.0003
839 DYSARTHRIA 10 0.0003
840 LUNG DISORDER 13 0.0003
841 HAEMATURIA 9 0.0003
842 RENAL IMPAIRMENT 22 0.0003
843 DEVICE RELATED INFECTION 4 0.0003
844 BLOOD BILIRUBIN INCREASED 7 0.0003
845 BASAL CELL CARCINOMA 4 0.0003
846 CHOKING 5 0.0003
847 ALOPECIA 50 0.0003
848 ABSCESS 4 0.0003
849 TACHYCARDIA 22 0.0002
850 FEEDING DISORDER 5 0.0002
851 INJURY ASSOCIATED WITH DEVICE 5 0.0002
852 DYSURIA 9 0.0002
853 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
854 INJURY 17 0.0002
855 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 43 0.0002
856 TYPE 2 DIABETES MELLITUS 8 0.0002
857 MOUTH ULCERATION 5 0.0002
858 ABDOMINAL PAIN LOWER 6 0.0002
859 HYPOPHAGIA 6 0.0002
860 DRY MOUTH 19 0.0002
861 SKIN ULCER 6 0.0002
862 HAEMATOMA 6 0.0002
863 AMNESIA 15 0.0002
864 RASH ERYTHEMATOUS 11 0.0002
865 BREAST CANCER 21 0.0002
866 NEOPLASM MALIGNANT 15 0.0002
867 COLITIS ULCERATIVE 10 0.0002
868 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
869 RASH PAPULAR 5 0.0002
870 DYSKINESIA 9 0.0002
871 CYSTITIS 7 0.0002
872 RESPIRATORY FAILURE 16 0.0002
873 SKIN IRRITATION 10 0.0002
874 ADVERSE EVENT 20 0.0002
875 SEPSIS 24 0.0002
876 THROMBOSIS 17 0.0002
877 DRUG INEFFECTIVE 277 0.0002
878 ANGINA PECTORIS 6 0.0002
879 ACUTE RESPIRATORY FAILURE 4 0.0002
880 INFECTION 30 0.0002
881 LOCALISED INFECTION 5 0.0002
882 DYSTONIA 4 0.0002
883 HYPOGLYCAEMIA 10 0.0002
884 OEDEMA 11 0.0002
885 NIGHTMARE 7 0.0002
886 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
887 DYSGEUSIA 15 0.0002
888 PRODUCT QUALITY ISSUE 27 0.0002
889 APHASIA 6 0.0002
890 LACRIMATION INCREASED 6 0.0002
891 PSORIATIC ARTHROPATHY 8 0.0002
892 OEDEMA PERIPHERAL 24 0.0002
893 BLINDNESS 8 0.0002
894 DRY SKIN 26 0.0002
895 UNRESPONSIVE TO STIMULI 5 0.0002
896 ARRHYTHMIA 9 0.0002
897 KNEE ARTHROPLASTY 4 0.0002
898 HOSPITALISATION 29 0.0002
899 IMPAIRED WORK ABILITY 4 0.0002
900 FAECES DISCOLOURED 4 0.0002
901 DIABETES MELLITUS 14 0.0002
902 OSTEONECROSIS 6 0.0002
903 EMOTIONAL DISTRESS 22 0.0002
904 STOMATITIS 11 0.0002
905 MENTAL STATUS CHANGES 5 0.0002
906 DIARRHOEA 116 0.0002
907 CONFUSIONAL STATE 29 0.0002
908 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
909 DRUG INTOLERANCE 17 0.0002
910 PROSTATE CANCER 14 0.0002
911 ECZEMA 9 0.0002
912 HYPOXIA 6 0.0002
913 PANCREATITIS 9 0.0002
914 BRADYCARDIA 9 0.0002
915 DRUG DOSE OMISSION 28 0.0002
916 WHEEZING 10 0.0002
917 ANAEMIA 32 0.0002
918 ADVERSE DRUG REACTION 15 0.0002
919 BLOOD PRESSURE FLUCTUATION 4 0.0002
920 THERAPEUTIC RESPONSE DECREASED 10 0.0002
921 HYPOTENSION 33 0.0002
922 ATRIAL FIBRILLATION 16 0.0002
923 SUICIDAL IDEATION 15 0.0002
924 ABASIA 4 0.0002
925 HYPERTENSION 34 0.0002
926 FLATULENCE 9 0.0002
927 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 32 0.0002
928 HAEMATEMESIS 4 0.0002
929 EYE IRRITATION 9 0.0002
930 ERECTILE DYSFUNCTION 4 0.0002
931 DRUG RESISTANCE 4 0.0002
932 THERAPY INTERRUPTED 11 0.0002
933 APPLICATION SITE ERYTHEMA 4 0.0002
934 FUNGAL INFECTION 5 0.0001
935 MYOCARDIAL INFARCTION 26 0.0001
936 FEAR 4 0.0001
937 ILL-DEFINED DISORDER 9 0.0001
938 GASTRIC DISORDER 5 0.0001
939 ABNORMAL DREAMS 4 0.0001
940 CHRONIC KIDNEY DISEASE 11 0.0001
941 DEMENTIA 4 0.0001
942 HYPERKALAEMIA 5 0.0001
943 BLISTER 8 0.0001
944 INTENTIONAL DOSE OMISSION 4 0.0001
945 DEEP VEIN THROMBOSIS 9 0.0001
946 WHITE BLOOD CELL COUNT DECREASED 15 0.0001
947 DRUG EFFECT INCOMPLETE 5 0.0001
948 LIVER FUNCTION TEST ABNORMAL 4 0.0001
949 SURGERY 8 0.0001
950 INTESTINAL OBSTRUCTION 5 0.0001
951 OFF LABEL USE 116 0.0001
952 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
953 DISORIENTATION 5 0.0001
954 PRODUCTIVE COUGH 6 0.0001
955 SKIN BURNING SENSATION 9 0.0001
956 HAEMORRHAGE 13 0.0001
957 HYPONATRAEMIA 7 0.0001
958 NEUTROPHIL COUNT DECREASED 5 0.0001
959 RENAL FAILURE 16 0.0001
960 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
961 HYPOKALAEMIA 5 0.0001
962 CEREBROVASCULAR ACCIDENT 18 0.0001
963 ACNE 8 0.0001
964 AGGRESSION 5 0.0001
965 SKIN EXFOLIATION 8 0.0001
966 PLATELET COUNT DECREASED 10 0.0001
967 EPISTAXIS 7 0.0001
968 ANGIOEDEMA 4 0.0001
969 CARDIAC FAILURE 7 0.0001
970 NO ADVERSE EVENT 15 0.0001
971 AGITATION 6 0.0001
972 INTENTIONAL PRODUCT MISUSE 7 0.0001
973 DRUG EFFECT DECREASED 4 0.0001
974 CARDIAC ARREST 6 0.0001
975 GASTROINTESTINAL HAEMORRHAGE 6 0.0001
976 CARDIAC FAILURE CONGESTIVE 5 0.0001
977 DISEASE PROGRESSION 7 0.0001
978 DEVICE MALFUNCTION 4 0.0001
979 PRODUCT USE ISSUE 10 0.0001
980 DEATH 43 0.0000
981 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
982 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
983 PSORIASIS 5 0.0000
984 OVERDOSE 8 0.0000
985 ACUTE KIDNEY INJURY 5 0.0000
986 DRUG INTERACTION 5 0.0000